Known, unknown, and estimated
- Known: the exact identity and event details when entered from a reliable source.
- Known: CJC-1295 with DAC has published human study data showing prolonged activity.
- Unknown: the true identity of ambiguously labeled products and exact personal exposure.
- Estimate: any curve depends on the selected form, source, and model assumptions.
The strongest CJC-1295 search-intent angle
Searches for “CJC-1295 tracker app” and “CJC-1295 peptide tracker” did not reveal a clear dedicated app landing page in the results inspected on June 11, 2026. Exact volume is unknown. The most defensible opportunity is not generic tracking; it is resolving the high-consequence naming confusion between CJC-1295 with DAC and products described as no DAC or modified GRF 1-29.
The record fields that prevent identity drift
Exact label
Record with DAC, no DAC, modified GRF 1-29, or unknown exactly as sourced.
Evidence source
Attach the study or profile that supports the selected model context.
Event record
Amount, unit, route, date, time, site, status, and supply record.
Model lock
Never reuse the with-DAC assumption for a no-DAC or unknown record.
Why a generic CJC-1295 field is not enough
With-DAC and no-DAC labels refer to materially different pharmacokinetic contexts. Ambiguous marketplace language makes exact product identity an additional unknown. The tracker should surface that uncertainty instead of choosing a model silently.
What the app does not establish
A record cannot authenticate a product, establish an approved human protocol, or prove safety or efficacy. CJC-1295 is not FDA approved. Model outputs remain estimates.
Primary source: human CJC-1295 with-DAC study. Supporting profiles: with DAC and no DAC or modified GRF 1-29.
Keep the complete record in one place
Halflife - Peptide & GLP-1 Log organizes logs, schedules, vial inventory, injection sites, symptoms, and clearly labeled model estimates on iPhone.
Download Halflife - Peptide & GLP-1 Log